XRAY: the balance sheet

MyFinsight

For the quarter ending 2026-03-31, XRAY has $5,229M in assets. $3,910M in debts. $190M in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
152.86%
Quick Ratio
98.26%
Cash Ratio
15.74%
Debt to Asset Ratio
74.78%
Unit: Million (M) dollars
Assets Breakdown
Gross carrying amount
Accumulated amortization
Property, plant, and equipment, ...
Others
Liabilities Breakdown
Capital in excess of par value
Treasury stock, at cost, 64.2 mi...
Long-term debt
Others

Balance Sheets	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Cash and cash equivalents	190	326	363	359
Accounts and notes receivable-trade, net	622	688	654	646
Inventories, net	659	642	686	675
Prepaid expenses and other current assets	374	367	369	286
Total current assets	1,845	2,023	2,072	1,966
Property, plant, and equipment, net	858	861	841	840
Operating lease right-of-use assets, net	139	139	131	139
Gross carrying amount	2,978	3,007	-	-
Accumulated amortization	2,306	2,289	-	-
Net carrying amount	672	718	-	-
Indefinite-lived intangible assets (excluding goodwill)	252	256	-	-
Identifiable intangible assets, net	924	974	1,065	1,133
Goodwill	1,142	1,148	1,270	1,528
Other noncurrent assets	321	284	274	463
Total assets	5,229	5,429	5,653	6,069

Accounts payable	259	300	268	268
Accrued liabilities	688	700	712	672
Income taxes payable	30	30	47	42
Notes payable and current portion of long-term debt	230	313	378	184
Total current liabilities	1,207	1,343	1,405	1,166
Long-term debt	2,006	2,015	2,017	2,218
Operating lease liabilities	95	93	85	92
Deferred income taxes	84	94	95	109
Other noncurrent liabilities	518	544	573	523
Total liabilities	3,910	4,089	4,175	4,108
Preferred stock, 1.00 par value 0.25 million shares authorized no shares issued	0	0	0	0
Common stock, 0.01 par value 400.0 million shares authorized, and 264.5 million shares issued at march31, 2026 and december31, 2025 199.5 million and 199.6 million shares outstanding at march31, 2026 and december31, 2025	3	3	3	3
Capital in excess of par value	6,616	6,644	6,638	6,638
Accumulated deficit	-1,574	-1,564	-1,385	-925
Accumulated other comprehensive loss	-655	-639	-672	-641
Treasury stock, at cost, 64.2 million and 64.9 million shares at march31, 2026 and december31, 2025, respectively	3,072	3,105	3,106	3,115
Total dentsply sirona equity	1,318	1,339	1,478	1,960
Noncontrolling interests	1	1	0	1
Total equity	1,319	1,340	1,478	1,961
Total liabilities and equity	5,229	5,429	5,653	6,069

Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

MyFinsight

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets